🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
ZBH
NYSE
🇺🇸 US
Zimmer Biomet Holdings, Inc.
Healthcare
43Score
DipBuster Score™
$87.97
+$0.81 (+0.93%)
Live price · Source: Yahoo
52-Week Position
$79.12
30% of range
$108.29
Beta
0.472
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.472
52W High$108.29
52W Low$79.12
🤖
Watch — Score 43/100
Zone: Buy Zone
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt CapN/A
52W Position30% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.472
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Zimmer Biomet Holdings, Inc. free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
28/25
Momentum & Volume
10/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
🟡
Watch
DipBuster Score: 43/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, A…
Sector
Healthcare
Market
🇺🇸 US
CEO
Ivan Tornos
Staff
17,000 employees
Website